zoledronic acid has been researched along with Eye Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khalid, MF; Micieli, J | 1 |
| Ávila, MP; de Oliveira Fagundes, WB; Freitas, LG; Freitas-Neto, CA; Pacheco, KD; Ribeiro, M | 1 |
| Francis, IC; Hooper, MJ; Masselos, K; Ooi, JL; Sharma, NS | 1 |
| Atik, OS | 1 |
4 other study(ies) available for zoledronic acid and Eye Diseases
| Article | Year |
|---|---|
Zoledronic acid-induced orbital inflammation.
Topics: Bone Density Conservation Agents; Diphosphonates; Eye Diseases; Humans; Inflammation; Neurology; Zoledronic Acid | 2021 |
Unilateral uveitis with vitreous haze following zoledronic Acid therapy for osteoporosis.
Topics: Aged; Bone Density Conservation Agents; Diphosphonates; Eye Diseases; Female; Fluorescein Angiography; Humans; Imidazoles; Infusions, Intravenous; Intraocular Pressure; Osteoporosis, Postmenopausal; Tomography, Optical Coherence; Ultrasonography; Uveitis; Visual Acuity; Vitreous Body; Zoledronic Acid | 2015 |
Zoledronic acid infusion and orbital inflammatory disease.
Topics: Bone Density Conservation Agents; Diphosphonates; Eye Diseases; Humans; Imidazoles; Male; Middle Aged; Orbital Cellulitis; Radiography; Zoledronic Acid | 2008 |
What do we know about the ocular adverse effects associated with intravenous bisphosphonates?
Topics: Bone Density Conservation Agents; Diphosphonates; Eye Diseases; Humans; Imidazoles; Inflammation; Infusions, Intravenous; Osteoporosis, Postmenopausal; Zoledronic Acid | 2011 |